Characteristics | Adherence (%) | OR | CI at 95% | p-value |
Type of cohort |
|
|
| 0.029 |
· During COVID-19 | 75 (72.8) | 1 | - |
|
· Before COVID-19 | 65 (58.6) | 1.90 | 1.10 - 3.37 |
|
Type of tuberculosis |
|
|
| 0.317 |
· Extra-pulmonary | 23 (74.2) | 1 | - |
|
· Pulmonary | 111 (64.9) | 1.55 | 0.65 - 3.69 |
|
Knowledge of treatment duration |
|
|
| 0.509 |
· Yes | 125 (64.4) | 1 | - |
|
· No | 6 (54.5) | 1.51 | 0.44 - 5.13 |
|
Presence of undesirable effects |
|
|
| <0.001 |
· Yes | 67 (50.0) | 9.14 | 3.91 - 21.40 |
|
· No | 64 (90.1) | 1 | - |
|